Ma Kun, Lu Mingjing, Li Hao, Yuan Xin, Zhang Ying, Ni Qiuying, Li Yun, Dong Xiaolin, Guo Jingjing
Department of Pediatrics, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
Qilu Institute of Technology, Jinan, China.
Front Pediatr. 2025 Aug 22;13:1644231. doi: 10.3389/fped.2025.1644231. eCollection 2025.
Doxycycline is traditionally avoided in children under 8 years due to concerns about permanent tooth discoloration. This meta-analysis aimed to assess the incidence of tooth discoloration in children treated with doxycycline and identify influencing factors. A systematic search of PubMed, Embase, Web of Science, Wanfang, and CNKI was conducted up to January 14, 2025, for studies reporting tooth discoloration in children (<18 years) treated with doxycycline. Pooled incidence was estimated using a random-effects model. Subgroup and univariate meta-regression analyses explored potential modifiers. Seventeen studies comprising 1,025 children were included. The pooled incidence of tooth discoloration was 0.92% (95% CI: 0.34%-1.50%) with no significant heterogeneity (I² < 0%). Subgroup analyses showed no significant differences by region, study design, age group, administration route, or assessment method. Meta-regression indicated no significant effects from publication year, sample size, mean age, dose, treatment duration, follow-up length, or study quality. The incidence of tooth discoloration following doxycycline use in children is low. These findings support the potential safety of doxycycline in pediatric populations, including those under 8 years of age, when clinically warranted.
PROSPERO (CRD420251009690).
由于担心永久性牙齿变色,传统上8岁以下儿童避免使用多西环素。本荟萃分析旨在评估接受多西环素治疗的儿童牙齿变色的发生率,并确定影响因素。截至2025年1月14日,对PubMed、Embase、Web of Science、万方和知网进行了系统检索,以查找报告接受多西环素治疗的儿童(<18岁)牙齿变色情况的研究。使用随机效应模型估计合并发生率。亚组和单变量荟萃回归分析探索了潜在的修饰因素。纳入了17项研究,共1025名儿童。牙齿变色的合并发生率为0.92%(95%CI:0.34%-1.50%),无显著异质性(I²<0%)。亚组分析显示,按地区、研究设计、年龄组、给药途径或评估方法划分,无显著差异。荟萃回归表明,发表年份、样本量、平均年龄、剂量、治疗持续时间、随访长度或研究质量无显著影响。儿童使用多西环素后牙齿变色的发生率较低。这些发现支持了多西环素在儿科人群(包括8岁以下儿童)中临床必要时的潜在安全性。
PROSPERO(CRD420251009690)。